Director, COO of Isis Pharmaceuticals Inc. (ISIS, Financial) B Lynne Parshall sells 45,000 shares of ISIS on 12/07/2009 at an average price of $10.53 a share.
Isis Pharmaceuticals, Inc. is a leading genomics-based drug discoveryand development company that is focused on RNA. RNA is a novel target for drug discovery, and Isis has established a dominant position in RNA research. The company has integrated the expertise in molecular and cellular biology, medicinal chemistry, RNA biochemistry, bioinformatics, pharmacology and clinical development to create two exciting technologies, antisense and Ibis, a robust pipeline of drugs in development and genomics services. Isis Pharmaceuticals Inc. has a market cap of $1.04 billion; its shares were traded at around $10.53 with and P/S ratio of 9.7.
ISIS is in the portfolios of Bruce Kovner of Caxton Associates.
Isis Pharmaceuticals, Inc. is a leading genomics-based drug discoveryand development company that is focused on RNA. RNA is a novel target for drug discovery, and Isis has established a dominant position in RNA research. The company has integrated the expertise in molecular and cellular biology, medicinal chemistry, RNA biochemistry, bioinformatics, pharmacology and clinical development to create two exciting technologies, antisense and Ibis, a robust pipeline of drugs in development and genomics services. Isis Pharmaceuticals Inc. has a market cap of $1.04 billion; its shares were traded at around $10.53 with and P/S ratio of 9.7.
ISIS is in the portfolios of Bruce Kovner of Caxton Associates.
Insiders' Positions with ISIS
- Sell:: Senior Vice President C Frank Bennett sold 12,000 shares of ISIS stock on 07/23/2009 at the average price of 17.03, the price of the stock has decreased by 38.17% since
- Sell:: Senior Vice President C Frank Bennett sold 12,000 shares of ISIS stock on 07/23/2009 at the average price of 17.03, the price of the stock has decreased by 38.17% since
- Sell:: Senior Vice President C Frank Bennett sold 12,000 shares of ISIS stock on 07/23/2009 at the average price of 17.03, the price of the stock has decreased by 38.17% since
- Sell:: Director, COO B Lynne Parshall sold 876 shares of ISIS stock on 07/06/2009 at the average price of 15.71, the price of the stock has decreased by 32.97% since
- Sell:: Senior Vice President Richard S Geary sold 387 shares of ISIS stock on 07/02/2009 at the average price of 15.89, the price of the stock has decreased by 33.73% since
